The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
Mechanisms of long COVID and the path toward therapeutics
Open accessAbstract
Long COVID, a type of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC) defined by medically unexplained symptoms following infection with SARS-CoV-2, is a newly recognized infection-associated chronic condition that causes disability in some people. Substantial progress has been made in defining its epidemiology, biology, and pathophysiology. However, there is no cure for the tens of millions of people believed to be experiencing long COVID, and industry engagement in developing therapeutics has been limited. Here, we review the current state of knowledge regarding the biology and pathophysiology of long COVID, focusing on how the proposed mechanisms explain the physiology of the syndrome and how they provide a rationale for the implementation of a broad experimental medicine and clinical trials agenda. Progress toward preventing and curing long COVID and other infection-associated chronic conditions will require deep and sustained investment by funders and industry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049 · cited 1×
“205 However, the recent discovery of the potentially causal role of EBV in multiple sclerosis 206 through mechanisms such as molecular mimicry 207 suggests that relationships between EBV and some of the autoimmune processes outlined above may exist.”
BackgroundMicroglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999
Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00676-0 · Cited by 1,983
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., Lange, F., Andersson, J. L. R., Griffanti, L., Duff, E., et al. (2022) · Nature · doi:10.1038/s41586-022-04569-5 · Cited by 1,646
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537
Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Quincy Brown, J., & Vander Heide, R. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,526
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 2×
“1,2,18,291,292 Studies have begun to suggest several sex-based biological differences inimmuneresponses (higher anti-EBVresponses,higher frequencies of cytolytic, tissue homing T cell subsets), 135,293 which can be broadly summarized as a general exaggeration of both innate and adaptive immune…”
BackgroundPrinciples and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · cited 1×
“269 Alterations in the HPA axis in long COVID have been suggested.”
BackgroundYeoh, Y. K., Zuo, T., Lui, G. C.-Y., Zhang, F., Liu, Q., Li, A. Y., Chung, A. C., Cheung, C. P., Tso, E. Y., Fung, K. S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323020 · Cited by 1,317
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Choi, B., Choudhary, M. C., Regan, J., Sparks, J. A., Padera, R. F., Qiu, X., Solomon, I. H., Kuo, H.-H., Boucau, J., Bowman, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2031364 · Cited by 1,246
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105911 · Cited by 1,046
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Diverse functional autoantibodies in patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 992
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Stein, S. R., Ramelli, S. C., Grazioli, A., Chung, J.-Y., Singh, M., Yinda, C. K., Winkler, C. W., Sun, J., Dickey, J. M., Ylaya, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05542-y · Cited by 991
Collaborators, G. B. O. D. L. C., Wulf Hanson, S., Abbafati, C., Aerts, J. G., Al-Aly, Z., Ashbaugh, C., Ballouz, T., Blyuss, O., Bobkova, P., Bonsel, G., et al. (2022) · JAMA · doi:10.1001/jama.2022.18931 · Cited by 970
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103417 · Cited by 941
Merkler, A. E., Parikh, N. S., Mir, S., Gupta, A., Kamel, H., Lin, E., Lantos, J., Schenck, E. J., Goyal, P., Bruce, S. S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2730 · Cited by 940
Considering how biological sex impacts immune responses and COVID-19 outcomes
Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0348-8 · Cited by 932
Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 927
How and why patients made Long Covid
Callard, F., & Perego, E. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113426 · Cited by 924
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04432-7 · Cited by 908
Long COVID after breakthrough SARS-CoV-2 infection
Al-Aly, Z., Bowe, B., & Xie, Y. (2022) · Nature Medicine · doi:10.1038/s41591-022-01840-0 · Cited by 866
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Thaweethai, T., Jolley, S. E., Karlson, E. W., Levitan, E. B., Levy, B., McComsey, G. A., McCorkell, L., Nadkarni, G. N., Parthasarathy, S., Singh, U., et al. (2023) · JAMA · doi:10.1001/jama.2023.8823 · Cited by 842
Self-citationDistinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., Tabacof, L., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 806
Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis
Tsampasian, V., Elghazaly, H., Chattopadhyay, R., Debski, M., Naing, T. K. P., Garg, P., Clark, A., Ntatsaki, E., & Vassiliou, V. S. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0750 · Cited by 799
Cytokine, Sickness Behavior, and Depression
Dantzer, R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.002 · Cited by 789
Neutralizing monoclonal antibodies for treatment of COVID-19
Taylor, P. C., Adams, A. C., Hufford, M. M., de la Torre, I., Winthrop, K., & Gottlieb, R. L. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00542-x · Cited by 732
Marconi, V. C., Ramanan, A. V., de Bono, S., Kartman, C. E., Krishnan, V., Liao, R., Piruzeli, M. L. B., Goldman, J. D., Alatorre-Alexander, J., de Cassia Pellegrini, R., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00331-3 · Cited by 695
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”
Graham, E. L., Clark, J. R., Orban, Z. S., Lim, P. H., Szymanski, A. L., Taylor, C., DiBiase, R. M., Jia, D. T., Balabanov, R., Ho, S. U., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51350 · Cited by 693
Furman, D., Hejblum, B. P., Simon, N., Jojic, V., Dekker, C. L., Thiébaut, R., Tibshirani, R. J., & Davis, M. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321060111 · Cited by 673
Brunoni, A. R., & Vanderhasselt, M.-A. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2014.01.008 · Cited by 669
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
TLR7 escapes X chromosome inactivation in immune cells
Souyris, M., Cenac, C., Azar, P., Daviaud, D., Canivet, A., Grunenwald, S., Pienkowski, C., Chaumeil, J., Mejía, J. E., & Guéry, J.-C. (2018) · Science Immunology · doi:10.1126/sciimmunol.aap8855 · Cited by 641
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Bowe, B., Xie, Y., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-02051-3 · Cited by 639
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Junqueira, C., Crespo, Â., Ranjbar, S., de Lacerda, L. B., Lewandrowski, M., Ingber, J., Parry, B., Ravid, S., Clark, S., Schrimpf, M. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04702-4 · Cited by 631
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Manry, J., Michailidis, E., Hoffmann, H.-H., Eto, S., Garcia-Prat, M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl4340 · Cited by 610
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records
Thompson, E. J., Williams, D. M., Walker, A. J., Mitchell, R. E., Niedzwiedz, C. L., Yang, T. C., Huggins, C. F., Kwong, A. S. F., Silverwood, R. J., Di Gessa, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30836-0 · Cited by 600
TLR7 gain-of-function genetic variation causes human lupus
Brown, G. J., Cañete, P. F., Wang, H., Medhavy, A., Bones, J., Roco, J. A., He, Y., Qin, Y., Cappello, J., Ellyard, J. I., et al. (2022) · Nature · doi:10.1038/s41586-022-04642-z · Cited by 596
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
Meier, A., Chang, J. J., Chan, E. S., Pollard, R. B., Sidhu, H. K., Kulkarni, S., Wen, T. F., Lindsay, R. J., Orellana, L., Mildvan, D., et al. (2009) · Nature Medicine · doi:10.1038/nm.2004 · Cited by 594
A Critical Appraisal of “Chronic Lyme Disease”
Feder, H. M., Johnson, B. J. B., O'Connell, S., Shapiro, E. D., Steere, A. C., & Wormser, G. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072023 · Cited by 578
Marchetti, C., Swartzwelter, B., Gamboni, F., Neff, C. P., Richter, K., Azam, T., Carta, S., Tengesdal, I., Nemkov, T., D’Alessandro, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716095115 · Cited by 574
Swank, Z., Senussi, Y., Manickas-Hill, Z., Yu, X. G., Li, J. Z., Alter, G., & Walt, D. R. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac722 · Cited by 572
Risks and burdens of incident diabetes in long COVID: a cohort study
Xie, Y., & Al-Aly, Z. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00044-4 · Cited by 564
Seeßle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., Müller, B., & Merle, U. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab611 · Cited by 540
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
Liu, Q., Mak, J. W. Y., Su, Q., Yeoh, Y. K., Lui, G. C.-Y., Ng, S. S. S., Zhang, F., Li, A. Y. L., Lu, W., Hui, D. S.-C., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325989 · Cited by 537
Venkatesan, P. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00031-x · Cited by 532
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
Fernández-Castañeda, A., Lu, P., Geraghty, A. C., Song, E., Lee, M.-H., Wood, J., O’Dea, M. R., Dutton, S., Shamardani, K., Nwangwu, K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.008 · Cited by 521
Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J. A., Laubscher, G. J., Steenkamp, J., & Kell, D. B. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01359-7 · Cited by 518
New-onset IgG autoantibodies in hospitalized patients with COVID-19
Chang, S. E., Feng, A., Meng, W., Apostolidis, S. A., Mack, E., Artandi, M., Barman, L., Bennett, K., Chakraborty, S., Chang, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25509-3 · Cited by 489
Merlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
Greene, C., Connolly, R., Brennan, D., Laffan, A., O’Keeffe, E., Zaporojan, L., O’Callaghan, J., Thomson, B., Connolly, E., Argue, R., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01576-9 · Cited by 429
Endothelium-Dependent Effects of Statins
Wolfrum, S., Jensen, K. S., & Liao, J. K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000063385.12476.a7 · Cited by 417
The neurobiology of long COVID
Monje, M., & Iwasaki, A. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.006 · Cited by 415
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Aydillo, T., Gonzalez-Reiche, A. S., Aslam, S., van de Guchte, A., Khan, Z., Obla, A., Dutta, J., van Bakel, H., Aberg, J., García-Sastre, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2031670 · Cited by 415
Natarajan, A., Zlitni, S., Brooks, E. F., Vance, S. E., Dahlen, A., Hedlin, H., Park, R. M., Han, A., Schmidtke, D. T., Verma, R., et al. (2022) · Med · doi:10.1016/j.medj.2022.04.001 · Cited by 415
Sex differences in vaccine-induced humoral immunity
Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H., & Alter, G. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0726-5 · Cited by 410
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Cervia-Hasler, C., Brüningk, S. C., Hoch, T., Fan, B., Muzio, G., Thompson, R. C., Ceglarek, L., Meledin, R., Westermann, P., Emmenegger, M., et al. (2024) · Science · doi:10.1126/science.adg7942 · Cited by 408
Yin, K., Peluso, M. J., Luo, X., Thomas, R., Shin, M.-G., Neidleman, J., Andrew, A., Young, K. C., Ma, T., Hoh, R., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01724-6 · Cited by 394
Self-citationTwo-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J., & Boyton, R. J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00904-7 · Cited by 389
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 371
Muscle abnormalities worsen after post-exertional malaise in long COVID
Appelman, B., Charlton, B. T., Goulding, R. P., Kerkhoff, T. J., Breedveld, E. A., Noort, W., Offringa, C., Bloemers, F. W., van Weeghel, M., Schomakers, B. V., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44432-3 · Cited by 360
Serotonin reduction in post-acute sequelae of viral infection
Wong, A. C., Devason, A. S., Umana, I. C., Cox, T. O., Dohnalová, L., Litichevskiy, L., Perla, J., Lundgren, P., Etwebi, Z., Izzo, L. T., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.013 · Cited by 357
Self-citationPersistent endotheliopathy in the pathogenesis of long COVID syndrome
Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J. M., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15490 · Cited by 337
Persistent Exertional Intolerance After COVID-19
Singh, I., Joseph, P., Heerdt, P. M., Cullinan, M., Lutchmansingh, D. D., Gulati, M., Possick, J. D., Systrom, D. M., & Waxman, A. B. (2022) · CHEST · doi:10.1016/j.chest.2021.08.010 · Cited by 336
Seillet, C., Laffont, S., Trémollières, F., Rouquié, N., Ribot, C., Arnal, J.-F., Douin-Echinard, V., Gourdy, P., & Guéry, J.-C. (2012) · Blood · doi:10.1182/blood-2011-08-371831 · Cited by 332
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Self-citationGlucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Mehdi, S. F., Pusapati, S., Anwar, M. S., Lohana, D., Kumar, P., Nandula, S. A., Nawaz, F. K., Tracey, K., Yang, H., LeRoith, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148209 · Cited by 317
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors
Cheong, J.-G., Ravishankar, A., Sharma, S., Parkhurst, C. N., Grassmann, S. A., Wingert, C. K., Laurent, P., Ma, S., Paddock, L., Miranda, I. C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.019 · Cited by 309
Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
Chang, R., Yen-Ting Chen, T., Wang, S.-I., Hung, Y.-M., Chen, H.-Y., & Wei, C.-C. J. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101783 · Cited by 308
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
Zollner, A., Koch, R., Jukic, A., Pfister, A., Meyer, M., Rössler, A., Kimpel, J., Adolph, T. E., & Tilg, H. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.037 · Cited by 307
Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.009 · Cited by 304
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 303
Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
Xie, Y., Choi, T., & Al-Aly, Z. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0743 · Cited by 303
Blitshteyn, S., & Whitelaw, S. (2021) · Immunologic Research · doi:10.1007/s12026-021-09185-5 · Cited by 301
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management
Bateman, L., Bested, A. C., Bonilla, H. F., Chheda, B. V., Chu, L., Curtin, J. M., Dempsey, T. T., Dimmock, M. E., Dowell, T. G., Felsenstein, D., et al. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.07.004 · Cited by 290
Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01825-0 · Cited by 290
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141772 · Cited by 281
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Proal, A. D., VanElzakker, M. B., Aleman, S., Bach, K., Boribong, B. P., Buggert, M., Cherry, S., Chertow, D. S., Davies, H. E., Dupont, C. L., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01601-2 · Cited by 281
Self-citationPatterson, B. K., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, M., Parikh, P., Guevara-Coto, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746021 · Cited by 280
Azzolini, E., Levi, R., Sarti, R., Pozzi, C., Mollura, M., Mantovani, A., & Rescigno, M. (2022) · JAMA · doi:10.1001/jama.2022.11691 · Cited by 255
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Peluso, M. J., Deveau, T.-M., Munter, S. E., Ryder, D., Buck, A., Beck-Engeser, G., Chan, F., Lu, S., Goldberg, S. A., Hoh, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163669 · Cited by 254
Self-citationThree-year outcomes of post-acute sequelae of COVID-19
Cai, M., Xie, Y., Topol, E. J., & Al-Aly, Z. (2024) · Nature Medicine · doi:10.1038/s41591-024-02987-8 · Cited by 254
Connors, J. M., Brooks, M. M., Sciurba, F. C., Krishnan, J. A., Bledsoe, J. R., Kindzelski, A., Baucom, A. L., Kirwan, B.-A., Eng, H., Martin, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.17272 · Cited by 251
Pretorius, E., Venter, C., Laubscher, G. J., Kotze, M. J., Oladejo, S. O., Watson, L. R., Rajaratnam, K., Watson, B. W., & Kell, D. B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01579-5 · Cited by 251
Peluso, M. J., Deitchman, A. N., Torres, L., Iyer, N. S., Munter, S. E., Nixon, C. C., Donatelli, J., Thanh, C., Takahashi, S., Hakim, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109518 · Cited by 248
Self-citationLescure, F.-X., Honda, H., Fowler, R. A., Lazar, J. S., Shi, G., Wung, P., Patel, N., Hagino, O., Bazzalo, I. J., Casas, M. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00099-0 · Cited by 246
Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women
Griesbeck, M., Ziegler, S., Laffont, S., Smith, N., Chauveau, L., Tomezsko, P., Sharei, A., Kourjian, G., Porichis, F., Hart, M., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501684 · Cited by 244
Sex-associated molecular differences for cancer immunotherapy
Ye, Y., Jing, Y., Li, L., Mills, G. B., Diao, L., Liu, H., & Han, L. (2020) · Nature Communications · doi:10.1038/s41467-020-15679-x · Cited by 243
Yonker, L. M., Gilboa, T., Ogata, A. F., Senussi, Y., Lazarovits, R., Boribong, B. P., Bartsch, Y. C., Loiselle, M., Rivas, M. N., Porritt, R. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149633 · Cited by 243
Vascular endothelial dysfunction and pharmacological treatment
Su, J. B. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.719 · Cited by 238
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Sherif, Z. A., Gomez, C. R., Connors, T. J., Henrich, T. J., Reeves, W. B., & RECOVER Mechanistic Pathway Task Force (2023) · eLife · doi:10.7554/elife.86002 · Cited by 237
Laffont, S., Rouquié, N., Azar, P., Seillet, C., Plumas, J., Aspord, C., & Guéry, J.-C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303400 · Cited by 233
van der Wijst, M. G. P., Vazquez, S. E., Hartoularos, G. C., Bastard, P., Grant, T., Bueno, R., Lee, D. S., Greenland, J. R., Sun, Y., Perez, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abh2624 · Cited by 233
HIV infection and coronary heart disease: mechanisms and management
Hsue, P. Y., & Waters, D. D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0219-9 · Cited by 229
Bramante, C. T., Buse, J. B., Liebovitz, D. M., Nicklas, J. M., Puskarich, M. A., Cohen, K., Belani, H. K., Anderson, B. J., Huling, J. D., Tignanelli, C. J., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00299-2 · Cited by 228
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19
Woodruff, M. C., Ramonell, R. P., Haddad, N. S., Anam, F. A., Rudolph, M. E., Walker, T. A., Truong, A. D., Dixit, A. N., Han, J. E., Cabrera-Mora, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05273-0 · Cited by 226
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
Augusto, D. G., Murdolo, L. D., Chatzileontiadou, D. S. M., Sabatino, J. J., Yusufali, T., Peyser, N. D., Butcher, X., Kizer, K., Guthrie, K., Murray, V. W., et al. (2023) · Nature · doi:10.1038/s41586-023-06331-x · Cited by 218
Self-citationUse of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post–Coronavirus Disease
Mancini, D. M., Brunjes, D. L., Lala, A., Trivieri, M. G., Contreras, J. P., & Natelson, B. H. (2021) · JACC: Heart Failure · doi:10.1016/j.jchf.2021.10.002 · Cited by 217
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0232-x · Cited by 213
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
Son, K., Jamil, R., Chowdhury, A., Mukherjee, M., Venegas, C., Miyasaki, K., Zhang, K., Patel, Z., Salter, B., Yuen, A. C. Y., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00970-2022 · Cited by 211
Wang, H., Peng, G., Bai, J., He, B., Huang, K., Hu, X., & Liu, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005025 · Cited by 197
Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
Weng, Y., Yao, J., Sparks, S., & Wang, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030523 · Cited by 192
Zuo, W., He, D., Liang, C., Du, S., Hua, Z., Nie, Q., Zhou, X., Yang, M., Tan, H., Xu, J., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00171-3 · Cited by 191
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients
Giron, L. B., Dweep, H., Yin, X., Wang, H., Damra, M., Goldman, A. R., Gorman, N., Palmer, C. S., Tang, H.-Y., Shaikh, M. W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686240 · Cited by 189
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts
Guarnieri, J. W., Dybas, J. M., Fazelinia, H., Kim, M. S., Frere, J., Zhang, Y., Soto Albrecht, Y., Murdock, D. G., Angelin, A., Singh, L. N., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1533 · Cited by 189
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodriguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 188
Self-citationMast cell activation symptoms are prevalent in Long-COVID
Weinstock, L. B., Brook, J. B., Walters, A. S., Goris, A., Afrin, L. B., & Molderings, G. J. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.043 · Cited by 185
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
Hellmuth, J. M., Barnett, T. A., Asken, B. M., Kelly, J. D., Torres, L., Stephens, M. L., Greenhouse, B., Martin, J. N., Chow, F. C., Deeks, S. G., et al. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00954-4 · Cited by 184
Self-citationData-driven identification of post-acute SARS-CoV-2 infection subphenotypes
Zhang, H., Zang, C., Xu, Z., Zhang, Y., Xu, J., Bian, J., Morozyuk, D., Khullar, D., Zhang, Y., Nordvig, A. S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02116-3 · Cited by 184
Cheung, C. C. L., Goh, D., Lim, X., Tien, T. Z., Lim, J. C. T., Lee, J. N., Tan, B., Tay, Z. E. A., Wan, W. Y., Chen, E. X., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-324280 · Cited by 180
Sex Differences in HIV Infection
Scully, E. P. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0383-2 · Cited by 179
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Peluso, M. J., Ryder, D., Flavell, R. R., Wang, Y., Levi, J., LaFranchi, B. H., Deveau, T., Buck, A. M., Munter, S. E., Asare, K. A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk3295 · Cited by 175
Self-citationType-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
Murira, A., & Lamarre, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00609 · Cited by 173
Peng, K., Li, X., Yang, D., Chan, S. C. W., Zhou, J., Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Wong, C. K. H., Chan, E. W., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102154 · Cited by 170
Guo, C., Che, X., Briese, T., Ranjan, A., Allicock, O., Yates, R. A., Cheng, A., March, D., Hornig, M., Komaroff, A. L., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.004 · Cited by 167
Xie, Y., Choi, T., & Al‐Aly, Z. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00684-9 · Cited by 167
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
Bridges, J. P., Vladar, E. K., Huang, H., & Mason, R. J. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217561 · Cited by 166
Guntur, V. P., Nemkov, T. G., de Boer, E., Mohning, M. P., Baraghoshi, D., Cendali, F. I., San-Millán, I., Petrache, I., & D’Alessandro, A. (2022) · Metabolites · doi:10.3390/metabo12111026 · Cited by 165
Trinath, J., Hegde, P., Sharma, M., Maddur, M. S., Rabin, M., Vallat, J.-M., Magy, L., Balaji, K. N., Kaveri, S. V., & Bayry, J. (2013) · Blood · doi:10.1182/blood-2012-11-468264 · Cited by 164
Kanberg, N., Simrén, J., Edén, A., Andersson, L.-M., Nilsson, S., Ashton, N. J., Sundvall, P.-D., Nellgård, B., Blennow, K., Zetterberg, H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103512 · Cited by 164
Sex-Based Differences in HIV Type 1 Pathogenesis
Addo, M. M., & Altfeld, M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu175 · Cited by 162
Català, M., Mercadé-Besora, N., Kolde, R., Trinh, N. T. H., Roel, E., Burn, E., Rathod-Mistry, T., Kostka, K., Man, W. Y., Delmestri, A., et al. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00414-9 · Cited by 162
Frontera, J. A., Boutajangout, A., Masurkar, A. V., Betensky, R. A., Ge, Y., Vedvyas, A., Debure, L., Moreira, A., Lewis, A., Huang, J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12556 · Cited by 159
S1-Leitlinie Post-COVID/Long-COVID
Koczulla, A. R., Ankermann, T., Behrends, U., Berlit, P., Böing, S., Brinkmann, F., Franke, C., Glöckl, R., Gogoll, C., Hummel, T., et al. (2021) · Pneumologie · doi:10.1055/a-1551-9734 · Cited by 158
Chronic Fatigue Syndrome: The Need for Subtypes
Jason, L. A., Corradi, K., Torres‐Harding, S., Taylor, R. R., & King, C. P. (2005) · Neuropsychology Review · doi:10.1007/s11065-005-3588-2 · Cited by 155
Webb, K., Peckham, H., Radziszewska, A., Menon, M., Oliveri, P., Simpson, F., Deakin, C. T., Lee, S. H., Ciurtin, C., Butler, G. E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03167 · Cited by 155
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Tesch, F., Ehm, F., Vivirito, A., Wende, D., Batram, M., Loser, F., Menzer, S., Jacob, J., Roessler, M., Seifert, M., et al. (2023) · Clinical Rheumatology · doi:10.1007/s10067-023-06670-0 · Cited by 153
Kenny, G., McCann, K., O’Brien, C., Savinelli, S., Tinago, W., Yousif, O., Lambert, J. S., O’Broin, C., Feeney, E. R., de Barra, E., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac060 · Cited by 152
Martínez-Colón, G. J., Ratnasiri, K., Chen, R., Jiang, S., ZANLEY, E. J., Rustagi, A., Verma, R., Chen, H. M., Andrews, J. R., Mertz, K. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9151 · Cited by 147
Geng, L. N., Bonilla, H. F., Hedlin, H., Jacobson, K. B., Tian, L., Jagannathan, P., Yang, P. C.-M., Subramanian, A. K., Liang, J. W., Shen, S., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.2007 · Cited by 147
Sites of feline coronavirus persistence in healthy cats
Kipar, A., Meli, M. L., Baptiste, K. E., Bowker, L. J., & Lutz, H. U. (2010) · Journal of General Virology · doi:10.1099/vir.0.020214-0 · Cited by 146
Florescu, S. A., Stanciu, D., Zaharia, M. F., Kosa, A. G., Codreanu, D. R., Kidwai, A., Masood, S., Kaye, C. T., Coutts, A., MacKay, L., et al. (2022) · JAMA · doi:10.1001/jama.2022.23257 · Cited by 145
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Hammond, J., Fountaine, R. J., Yunis, C., Fleishaker, D. L., Almas, M., Bao, W., Wisemandle, W., Baniecki, M. L., Hendrick, V. M., Kalfov, V., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309003 · Cited by 145
Bouck, E. G., Denorme, F., Holle, L. A., Middelton, E. A., Blair, A., de Laat, B., Schiffman, J. D., Yost, C. C., Rondina, M. T., Wolberg, A. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315338 · Cited by 143
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Woodruff, M. C., Bonham, K. S., Anam, F. A., Walker, T. A., Faliti, C. E., Ishii, Y., Kaminski, C. Y., Runnstrom, M. C., Cooper, K. R., Truong, A. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40012-7 · Cited by 143
Persistent serum protein signatures define an inflammatory subcategory of long COVID
Talla, A., Vasaikar, S. V., Szeto, G. L., Lemos, M. P., Czartoski, J., Macmillan, H., Moodie, Z., Cohen, K. W., Ballweber-Fleming, L., Thomson, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38682-4 · Cited by 141
Tejerina, F., Catalán, P., Rodríguez‐Grande, C., Adán‐Jiménez, J., Rodríguez, C., Muñóz, P., Aldámiz‐Echevarría, T., Díez, C., Latorre, L. P., Fanciulli, C., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07153-4 · Cited by 137
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
Ancona, G., Alagna, L., Alteri, C., Palomba, E., Tonizzo, A., Pastena, A., Muscatello, A., Gori, A., & Bandera, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1080043 · Cited by 135
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Ahamed, J., & Laurence, J. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161167 · Cited by 132
Peluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab640 · Cited by 131
Self-citationde Boer, E., Petrache, I., Goldstein, N. M., Olin, J. T., Keith, R. C., Modena, B., Mohning, M. P., Yunt, Z. X., San-Millán, I., & Swigris, J. J. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1903le · Cited by 130
Endothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128
Berger, J. S., Kornblith, L. Z., Gong, M. N., Reynolds, H. R., Cushman, M., Cheng, Y., McVerry, B. J., Kim, K. S., Lópes, R. D., Atassi, B., et al. (2022) · JAMA · doi:10.1001/jama.2021.23605 · Cited by 128
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
Faruqui, S., Okoli, F. C., Olsen, S. K., Feldman, D. M., Kalia, H. S., Park, J. S., Stanca, C. M., Diaz, V. F., Yuan, S., Dagher, N. N., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001264 · Cited by 127
Xiong, R., Gunter, C., Fleming, E. S., Vernon, S. D., Bateman, L., Unutmaz, D., & Oh, J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.001 · Cited by 127
Liew, F., Efstathiou, C., Fontanella, S., Richardson, M., Saunders, R., Swieboda, D. P., Sidhu, J. K., Ascough, S., Moore, S. C., Mohamed, N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01778-0 · Cited by 124
Taub, P. R., Zadourian, A., Lo, H. C., Ormiston, C. K., Golshan, S., & Hsu, J. C. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.029 · Cited by 122
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Peluso, M. J., Deeks, S. G., Mustapić, M., Kapogiannis, D., Henrich, T. J., Lu, S., Goldberg, S. A., Hoh, R., Chen, J. Y., Martinez, E. O., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26350 · Cited by 119
Self-citationMateu, L., Tebé, C., Loste, C., Santos, J. R., Lladós, G., López, C., España-Cueto, S., Toledo, R., Font, M., Chamorro, A., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100724 · Cited by 119
Douin‐Echinard, V., Laffont, S., Seillet, C., Delpy, L., Krust, A., Chambon, P., Gourdy, P., Arnal, J., & Guéry, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3661 · Cited by 118
COVID-19–Induced New-Onset Diabetes: Trends and Technologies
Metwally, A. A., Mehta, P., Johnson, B. S., Nagarjuna, A., & Snyder, M. P. (2021) · Diabetes · doi:10.2337/dbi21-0029 · Cited by 118
Fibrin drives thromboinflammation and neuropathology in COVID-19
Ryu, J. K., Yan, Z., Montano, M., Sozmen, E. G., Dixit, K., Suryawanshi, R. K., Matsui, Y., Helmy, E., Kaushal, P., Makanani, S. K., et al. (2024) · Nature · doi:10.1038/s41586-024-07873-4 · Cited by 116
Why does viral RNA sometimes persist after recovery from acute infections?
Griffin, D. E. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001687 · Cited by 116
A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J. F., & Hamaoka, T. (2015) · Scientific Reports · doi:10.1038/srep11601 · Cited by 115
Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form
Malkova, A. M., Kudryavtsev, I. V., Starshinova, A. A., Kudlay, D. A., Zinchenko, Y. S., Glushkova, A. V., Yаblonskiy, P. K., & Shoenfeld, Y. (2021) · Pathogens · doi:10.3390/pathogens10111408 · Cited by 115
Ajčević, M., Iscra, K., Furlanis, G., Michelutti, M., Miladinović, A., Stella, A. B., Ukmar, M., Cova, M. A., Accardo, A., & Manganotti, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-32275-3 · Cited by 113
An airway-to-brain sensory pathway mediates influenza-induced sickness
Bin, N.-R., Prescott, S. L., Horio, N., Wang, Y., Chiu, I. M., & Liberles, S. D. (2023) · Nature · doi:10.1038/s41586-023-05796-0 · Cited by 111
Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
Xie, Y., Choi, T., & Al‐Aly, Z. (2023) · BMJ · doi:10.1136/bmj-2022-074572 · Cited by 111
Lau, R. I., Su, Q., Lau, I. S. F., Ching, J. Y., Wong, M. C. S., Lau, L. H. S., Tun, H. M., Mok, C. K. P., Chau, S. W. H., Tse, Y. K., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00685-0 · Cited by 111
Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019
Szekely, Y., Lichter, Y., Sadon, S., Lupu, L., Taieb, P., Banai, A., Sapir, O. P. R., Granot, Y. N., Hochstadt, A., Friedman, S., et al. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.08.022 · Cited by 109
The Epidemiology of Long Coronavirus Disease in US Adults
Robertson, M. M., Qasmieh, S. A., Kulkarni, S., Teasdale, C. A., Jones, H. E., McNairy, M. L., Borrell, L. N., & Nash, D. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac961 · Cited by 106
Plasma-based antigen persistence in the post-acute phase of COVID-19
Peluso, M. J., Swank, Z., Goldberg, S. A., Lu, S., Dalhuisen, T., Borberg, E., Senussi, Y., Luna, M. A., Song, C. C., Clark, A., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00211-1 · Cited by 105
Self-citationShikova, E., Reshkova, V., Kumanova, А., Raleva, S. H., Alexandrova, D., Čapo, N., Murovska, M., & on behalf of the European Network on ME CFS (2020) · Journal of Medical Virology · doi:10.1002/jmv.25744 · Cited by 104
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course
Muri, J., Cecchinato, V., Cavalli, A., Shanbhag, A. A., Matkovic, M., Biggiogero, M., Maida, P. A., Moritz, J., Toscano, C., Ghovehoud, E., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01445-w · Cited by 104
Genome-wide association study of long COVID
Lammi, V., Nakanishi, T., Jones, S. E., Andrews, S. J., Karjalainen, J. M., Cortés, B., O’Brien, H., Ochoa-Guzmán, A., Fulton‐Howard, B., Broberg, M. E., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02100-w · Cited by 104
Pilloni, G., Vogel-Eyny, A., Lustberg, M., Best, P., Malík, M., Masters, L. W., George, A., Mirza, I., Ryerson, L. Z., Datta, A., et al. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.04.014 · Cited by 102
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Nunez-Castilla, J., Stebliankin, V., Baral, P., Balbin, C. A., Sobhan, M., Cickovski, T., Mondal, A. M., Narasimhan, G., Chapagain, P., Mathee, K., et al. (2022) · Viruses · doi:10.3390/v14071415 · Cited by 100
Hoel, H., Heggelund, L., Reikvam, D. H., Stiksrud, B., Ueland, T., Michelsen, A. E., Otterdal, K., Muller, K. E., Lind, A., Müller, F., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13178 · Cited by 99
Taquet, M., Skórniewska, Z., Hampshire, A., Chalmers, J. D., Ho, L., Horsley, A. R., Marks, M., Poinasamy, K., Raman, B., Leavy, O. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02525-y · Cited by 96
Cai, J., Lin, K., Zhang, H., Xue, Q., Zhu, K., Yuan, G., Sun, Y., Zhu, F., Ai, J., Wang, S., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2220578 · Cited by 95
Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis
Zhang, L., Gough, J. E., Christmas, D. M., Mattey, D. L., Richards, S., Main, J., Enlander, D., Honeybourne, D., Ayres, J. G., Nutt, D., et al. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.072561 · Cited by 93
Gottlieb, M. A., Wang, R. C., Yu, H., Spatz, E. S., Montoy, J. C. C., Rodriguez, R. M., Chang, A. M., Elmore, J. G., Hannikainen, P. A., Hill, M. J., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad045 · Cited by 93
Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID ‐19
Apple, A. C., Oddi, A., Peluso, M. J., Asken, B. M., Henrich, T. J., Kelly, J. D., Pleasure, S. J., Deeks, S. G., Allen, I. E., Martin, J. N., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51498 · Cited by 91
Self-citationPeluso, M. J., Sans, H. M., Forman, C. A., Nylander, A. N., Ho, H.-E., Lu, S., Goldberg, S. A., Hoh, R., Tai, V., Munter, S. E., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200003 · Cited by 90
Self-citationPrevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection
Litleskare, S., Rørtveit, G., Eide, G. E., Hanevik, K., Langeland, N., & Wensaas, K. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.022 · Cited by 89
Escape from X chromosome inactivation and female bias of autoimmune diseases
Mousavi, M. J., Mahmoudi, M., & Ghotloo, S. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00256-1 · Cited by 88
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome
Saito, S., Shahbaz, S., Luo, X., Osman, M. S., Redmond, D., Tervaert, J. W. C., Li, L., & Elahi, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341843 · Cited by 87
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
Xu, Q., Milanez‐Almeida, P., Martins, A. J., Radtke, A. J., Hoehn, K. B., Oguz, C., Chen, J., Liu, C., Tang, J., Grubbs, G., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01367-z · Cited by 86
Metadata
- Authors
- Peluso, M. J., & Deeks, S. G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 187
- Issue
- 20
- Pages
- 5500-5529
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4402830995
- Cited by
- 341
- References
- 285
- FWCI
- 78.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.